Advisory Committees

Briefing Information for the August 14, 2014 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)

 

Persons with disabilities having problems accessing the PDF file(s) below may call (301) 796-3634 for assistance

Boehringer Ingelheim Pharmaceuticals, Inc.

Disclaimer: The statements contained in this document(s) are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.

Page Last Updated: 09/01/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English